Dr Richard Goodfellow, joint Chief Executive Officer of Scancell, comments: ???We believe that The Journal of Clinical Investigation paper supports Scancell???s approach to fighting cancers, such as malignant melanoma, where T cell activation appears to be the more effective route of combating this often fatal disease.